Gene · 9113
NIH grants1,633
NIH grants whose papers are about the gene, through NIH's grant-paper links.
321 to 340 of 1,633
Download this page as JSON| Grant | Title | LATS1 papers | Newest fiscal year |
|---|---|---|---|
| R01HL124392 | Defining epithelial polarity cues that direct cell fate | 8 | 2024 |
| UL1TR001430 | Boston University Clinical and Translational Science Institute | 6 | 2024 |
| R01DK083450 | Conserved mechanisms in epithelial niche regulation of intestinal stem cells | 4 | 2024 |
| P01CA236585 | Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma | 3 | 2024 |
| P50CA070907 | Targeting Lung Cancer Vulnerabilities | 3 | 2024 |
| R01AI148431 | Human Papillomavirus Manipulation of Epithelial Differentiation | 3 | 2024 |
| F32DE032573 | Determining the mechanism for YAP1 activation by HPV E7 in oropharyngeal carcinoma | 2 | 2024 |
| R01CA237031 | Epigenetic modulation of the TAZ-CAMTA1 transcriptional program by the Ada2a-containing histone acetyltransferase complex | 2 | 2024 |
| R01CA247551 | Co-targeting the HER3 oncogenic signaling circuitry and PD-1 as a novel multimodal precision immunotherapy for HNSCC | 2 | 2024 |
| R01EY032149 | Interplay between AMPK and Hippo Signaling Regulates Ocular Antiviral Response to Zika virus infection | 2 | 2024 |
| R01HL112330 | REGULATION OF MYOCARDIAL GROWTH AND DEATH BY THE HIPPO PATHWAY | 2 | 2024 |
| R25GM086262 | University of Michigan Postbaccalaureate Research Education Program (UM PREP) | 2 | 2024 |
| R35ES028374 | Protein Kinase Signaling in the Genotoxic Stress Response | 2 | 2024 |
| U19AI149504 | (Attack)2: Genetic engineering of cellular and humoral immunity to cure HIV | 2 | 2024 |
| K22CA258805 | Targeted disruption of the YAP/TAZ/TEAD axis in pancreatic cancer | 1 | 2024 |
| P01AG014449 | Neurobiology of Mild Cognitive Impairment in the Elderly | 1 | 2024 |
| P01CA093900 | The Biology of Prostate Cancer Skeletal Metastases | 1 | 2024 |
| P01CA233452 | Determinants of Liver Metastasis | 1 | 2024 |
| P20GM104320 | Nebraska Center for the Prevention of Obesity Diseases through Dietary Molecules | 1 | 2024 |
| P30AG068345 | The University of Southern California and Buck Institute Nathan Shock Center | 1 | 2024 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9113/grants?page=17